Medineuron PG 1500mcg/75mg Tablet SR

Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain, seizures, and anxiety. The sustained-release formulation ensures a gradual and consistent release of both active ingredients, improving patient compliance and maintaining stable plasma concentrations over an extended period.

Medineuron PG is indicated for conditions such as diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and neuropathic pain associated with spinal cord injury. It may also be used adjunctively in partial seizures. The combination therapy addresses both symptomatic relief and underlying nerve repair mechanisms, offering a comprehensive approach to neuropathic conditions.

Patients should use this medication under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, and gastrointestinal disturbances.